Sjögren syndrome/scleroderma autoantigen 1 is a direct Tankyrase binding partner in cancer cells
Sjögren syndrome/scleroderma autoantigen 1 (SSSCA1) was first described as an auto-antigen over-expressed in Sjögren's syndrome and in scleroderma patients. SSSCA1 has been linked to mitosis and centromere association and as a potential marker candidate in diverse solid cancers. Here we charact...
Egile Nagusiak: | Perdreau-Dahl, H, Progida, C, Barfeld, SJ, Guldsten, H, Thiede, B, Arntzen, M, Bakke, O, Mills, IG, Krauss, S, Morth, JP |
---|---|
Formatua: | Journal article |
Hizkuntza: | English |
Argitaratua: |
Springer Nature
2020
|
Antzeko izenburuak
-
An Evolutionary Perspective on the Origin, Conservation and Binding Partner Acquisition of Tankyrases
nork: Sven T. Sowa, et al.
Argitaratua: (2022-11-01) -
Tankyrase 1 and tankyrase 2 are essential but redundant for mouse embryonic development.
nork: Y Jeffrey Chiang, et al.
Argitaratua: (2008-07-01) -
Tankyrase Inhibitors Stimulate the Ability of Tankyrases to Bind Axin and Drive Assembly of β-Catenin Degradation-Competent Axin Puncta.
nork: Estefania Martino-Echarri, et al.
Argitaratua: (2016-01-01) -
Regenerating Gene Protein as a Novel Autoantigen in the Pathogenesis of Sjögren’s Syndrome
nork: Takashi Fujimoto, et al.
Argitaratua: (2015-12-01) -
Histopathological differences between primary Sjögren's syndrome and Sjögren's syndrome accompanied by scleroderma
nork: Ulku Kucuk, et al.
Argitaratua: (2018-01-01)